Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
glutaredoxin 3 | 0.686 | 0.538 | 0.36 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
ADAM metallopeptidase domain 28 | 0.666 | 0.500 | 3.0E-24 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
TNF receptor superfamily member 13C | 0.540 | 0.731 | 0.27 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 4 | 0.455 | 0.846 | 1.00 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2007 | 2007 | ||||||||
|
acyl-CoA synthetase long chain family member 4 | 0.561 | 0.769 | 0.98 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2001 | 2001 | ||||||||
|
alkB homolog 3, alpha-ketoglutaratedependent dioxygenase | 0.670 | 0.462 | 2.7E-12 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
fibroblast growth factor receptor 4 | 0.490 | 0.769 | 7.2E-13 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
caspase 14 | 0.663 | 0.462 | 2.9E-06 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
integrator complex subunit 6 | 0.711 | 0.423 | 1.00 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2001 | 2001 | ||||||||
|
sushi repeat containing protein X-linked 2 | 0.621 | 0.462 | 4.8E-02 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2013 | 2013 | ||||||||
|
glutamate-cysteine ligase catalytic subunit | 0.509 | 0.885 | 0.43 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
glutamate-cysteine ligase modifier subunit | 0.588 | 0.846 | 0.99 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
heparin binding growth factor | 0.575 | 0.654 | 0.27 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
eukaryotic translation initiation factor 3 subunit E | 0.633 | 0.423 | 5.2E-02 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2001 | 2001 | ||||||||
|
lymphocyte activating 3 | 0.517 | 0.692 | 0.28 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
lymphotoxin alpha | 0.434 | 0.885 | 0.20 |
|
group | 0.010 | None | < 0.001 | 1 | 4 | 1994 | 1994 | ||||||||
|
SMAD family member 1 | 0.533 | 0.731 | 0.99 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | ||||||||
|
MAGE family member A4 | 0.653 | 0.346 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2001 | 2001 | |||||||||
|
metastasis associated 1 family member 3 | 0.670 | 0.462 | 3.4E-02 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
MOK protein kinase | 0.476 | 0.769 | 8.8E-22 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2005 | 2005 | ||||||||
|
tripartite motif containing 27 | 0.572 | 0.808 | 1.00 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2005 | 2005 | ||||||||
|
C-C motif chemokine ligand 16 | 0.686 | 0.500 | 0.22 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
synaptosome associated protein 25 | 0.489 | 0.808 | 0.99 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2001 | 2001 | ||||||||
|
bromodomain testis associated | 0.751 | 0.231 | 5.8E-09 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2005 | 2005 | ||||||||
|
transcription factor 21 | 0.537 | 0.692 | 0.83 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 |